http://orcid.org/0000-0002-0544-1409
Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Eyal Klang, Shelly Soffer, Eyal Shachar & Adi Lahat. (2022) Trends in inflammatory bowel disease infections and vaccinations in the past four decades: A high-level text mining analysis of PubMed publications. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Articles from other publishers (29)
Lanlan Li, Bingyu Chen, Gang Li, Sheng Chen & Jianxiang Zhang. (2023) Anti‐Inflammatory Nanotherapies Based on Bioactive Cyclodextrin Materials. Advanced NanoBiomed Research.
Crossref
Crossref
Jiajun Cai, Hui Tao, Huan Liu, Yi Hu, Songling Han, Wendan Pu, Lanlan Li, Gang Li, Chenwen Li & Jianxiang Zhang. (2023) Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells. Bioactive Materials 28, pages 12-26.
Crossref
Crossref
Pablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, Vipul Jairath, Maria T Abreu, David T Rubin, Walter Reinisch, Fernando Magro, Jean-François Rahier, Silvio Danese, Christian Rabaud & Laurent Peyrin-Biroulet. (2023) Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Crohn's and Colitis 17:2, pages 199-210.
Crossref
Crossref
Anna Röckert Tjernberg, Petter Malmborg & Karl Mårild. (2023) Coronavirus disease 2019 and gastrointestinal disorders in children. Therapeutic Advances in Gastroenterology 16, pages 175628482311776.
Crossref
Crossref
Constanze Heike Waggershauser, Cornelia Tillack-Schreiber, Paul Weyh, Eckard Alt, Thorsten Siegmund, Christine Berchthold-Benchieb, Daniel Szokodi, Fabian Schnitzler & Thomas Ochsenkühn. (2022) Impact of Immunotherapies on SARS-CoV-2-Infections and Other Respiratory Tract Infections during the COVID-19 Winter Season in IBD Patients. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-9.
Crossref
Crossref
Emma R. Brannon, M. Valentina Guevara, Noah J. Pacifici, Jonathan K. Lee, Jamal S. Lewis & Omolola Eniola-Adefeso. (2022) Polymeric particle-based therapies for acute inflammatory diseases. Nature Reviews Materials 7:10, pages 796-813.
Crossref
Crossref
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen & Florian Rieder. (2022) Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 102:2, pages 605-652.
Crossref
Crossref
Sanskriti Varma, Peter H. Green & Suneeta Krishnareddy. (2022) Clinical Factors Associated With Positive Stool PCR for Gastrointestinal Pathogens in Celiac and Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 56:3, pages e196-e202.
Crossref
Crossref
Ema Saltović, Brankica Mijandrušić-Sinčić, Alen Braut, Ivana Škrobonja, Ella Sever, Irena Glažar, Sonja Pezelj-Ribarić & Miranda Muhvić-Urek. (2022) Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α4β7 Therapy. Dentistry Journal 10:3, pages 32.
Crossref
Crossref
Marilia L. Montenegro, Juan E. Corral, Frank J. Lukens, Baoan Ji, Paul T. Kröner, Francis A. Farraye & Yan Bi. (2021) Pancreatic Disorders in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 67:2, pages 423-436.
Crossref
Crossref
Aman Sharma, Deepak Kumar, Pankaj Gupta, Vishal Sharma & Arup Choudhury. (2022) Forme Fruste of Septic Arthritis in a Patient with Ulcerative Colitis. Journal of Gastrointestinal Infections 11:1, pages 42-43.
Crossref
Crossref
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago & Roberto Grassia. (2021) Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 13:12, pages 1828-1849.
Crossref
Crossref
Tommaso Innocenti, Jenny Roselli, Erica N. Lynch, Pasquale Apolito, Laura Parisio, Siro Bagnoli, Giuseppe Macrì, Francesca Rogai, Mirko Tarocchi, Stefano Milani, Andrea Galli, Monica Milla & Gabriele Dragoni. (2021) Infectious risk of vedolizumab compared with other biological agents in the treatment of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 33:1S, pages e574-e579.
Crossref
Crossref
Giuseppe Losurdo, Irene Vita Brescia, Chiara Lillo, Martino Mezzapesa, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo & Maria Rendina. (2021) Liver involvement in inflammatory bowel disease: What should the clinician know?. World Journal of Hepatology 13:11, pages 1534-1551.
Crossref
Crossref
John Gubatan, Ole Haagen Nielsen, Steven Levitte, Carsten Bogh Juhl, Cynthia Maxwell, Sarah E. Streett & Aida Habtezion. (2021) Biologics During Pregnancy in Women With Inflammatory Bowel Disease and Risk of Infantile Infections: A Systematic Review and Meta-Analysis. American Journal of Gastroenterology 116:2, pages 243-253.
Crossref
Crossref
Shih-Wei Lai, Kuan-Fu Liao, Cheng-Li Lin, Yu-Hung Kuo, Chiu-Shong Liu & Bing-Fang Hwang. (2021) The incidence rate of herpes zoster in inflammatory bowel disease. Medicine 100:33, pages e26863.
Crossref
Crossref
Ivan Guerra, Alicia Algaba, Laura Jiménez, Mª Mar Aller, Daniel Garza, Daniel Bonillo, Laura María Molina Esteban & Fernando Bermejo. (2021) Incidence, Clinical Characteristics, and Evolution of SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: A Single-Center Study in Madrid, Spain. Inflammatory Bowel Diseases 27:1, pages 25-33.
Crossref
Crossref
Alexandra Garten Schmitt, Thomas Erwes & Lisa M. Chirch. 2021. Inflammatory Bowel Disease. Inflammatory Bowel Disease
137
170
.
Yin Dou, Chenwen Li, Lanlan Li, Jiawei Guo & Jianxiang Zhang. (2020) Bioresponsive drug delivery systems for the treatment of inflammatory diseases. Journal of Controlled Release 327, pages 641-666.
Crossref
Crossref
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo & Mariabeatrice Principi. (2020) Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study. Pathogens 9:11, pages 870.
Crossref
Crossref
MD.Salma MD.Salma, Y.Siva Y.Siva & , J.Bhargava Narendra , J.Bhargava Narendra. (2020) Case Report on Ulcerative Colitis in 16 year girl. World Journal of Current Medical and Pharmaceutical Research, pages 287-290.
Crossref
Crossref
Carlos A. A. de Brito, Claudia D. L. Marques, Rafael F. O. França, Janaína R. Monteiro, Marina C. M. de Brito, Fabiana Lopes, Anton Lima, Gabriel L. Marques, Maria Luisa Valadares & Angela L. B. P. Duarte. (2020) Reduced Duration of Postchikungunya Musculoskeletal Pain in Rheumatological Patients Treated with Biologicals. Journal of Tropical Medicine 2020, pages 1-6.
Crossref
Crossref
Balázs Koscsó, Sravya KurapatiRichard R. RodriguesJelena Nedjic, Kavitha GowdaChangsik ShinChetna Soni, Azree Zaffran AshrafIndira Purushothaman, Maryknoll Palisoc, Sulei XuHaoyu Sun, Sathi Babu Chodisetti, Eugene Lin, Matthias MackYuka Imamura Kawasawa, Pingnian He, Ziaur S. M. RahmanIannis Aifantis, Natalia ShulzhenkoAndrey Morgun & Milena Bogunovic. (2020)
Gut-resident CX3CR1
hi
macrophages induce tertiary lymphoid structures and IgA response in situ
. Science Immunology 5:46.
Crossref
Crossref
Iris Dotan, Matthieu Allez, Silvio Danese, Mary Keir, Swati Tole & Jacqueline McBride. (2019) The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies. Medicinal Research Reviews 40:1, pages 245-262.
Crossref
Crossref
Jiawei Guo, Dandan Li, Hui Tao, Gang Li, Renfeng Liu, Yin Dou, Taotao Jin, Lanlan Li, Jun Huang, Houyuan Hu & Jianxiang Zhang. (2019) Cyclodextrin‐Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases. Advanced Materials 31:46, pages 1904607.
Crossref
Crossref
Pei-Chi Lo, Akira Maeda, Tasuku Kodama, Chihiro Takakura, Tomohisa Yoneyama, Rieko Sakai, Yuki Noguchi, Rei Matsuura, Hiroshi Eguchi, Katsuyoshi Matsunami, Hiroomi Okuyama & Shuji Miyagawa. (2019) The novel immunosuppressant prenylated quinolinecarboxylic acid-18 (PQA-18) suppresses macrophage differentiation and cytotoxicity in xenotransplantation. Immunobiology 224:4, pages 575-584.
Crossref
Crossref
Shan-Shan Gong, Yi-Hong Fan, Qing-Qing Han, Bin Lv & Yi Xu. (2019) Nested case-control study on risk factors for opportunistic infections in patients with inflammatory bowel disease. World Journal of Gastroenterology 25:18, pages 2240-2250.
Crossref
Crossref
John Foerster & Aleksandra Molęda. (2019) Feasibility Analysis of Interleukin-13 as a Target for a Therapeutic Vaccine. Vaccines 7:1, pages 20.
Crossref
Crossref
Pablo A. Olivera, Juan S. Lasa, Ignacio Zubiaurre, Vipul Jairath, Maria T. Abreu, David T. Rubin, Walter Reinisch, Fernando Magro, Jean-François Rahier, Silvio Danese, Christian Rabaud & Laurent Peyrin-Biroulet. (2022) Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. SSRN Electronic Journal.
Crossref
Crossref